Education
About Us
Working with TipRanks
Follow Us
R Michael Carruthers Insider Profile
4 Followers
R Michael Carruthers, Chief Financial Officer at Fresh Tracks Therapeutics, holds ― shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds 86.16K shares in Edgewise Therapeutics (Ticker: EWTX), holds ― shares in Elevation Oncology (Ticker: ELEV). Most recently, R Michael Carruthers ― shares of Fresh Tracks Therapeutics on ― for an estimated value of ―.
R Michael Carruthers Fresh Tracks Therapeutics (FRTX)Chief Financial Officer
Fresh Tracks Therapeutics (FRTX)
Chief Financial Officer
Ranked #72,269 out of 106,131 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-22.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that R Michael Carruthers holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 24, 2024 - Sep 24, 2025
Return:+35.90%
The most profitable trade made by R Michael Carruthers
R Michael Carruthers's Trading History
Fresh Tracks Therapeutics
―
―
―
―
Edgewise Therapeutics
Aug 14, 2025
CFO
Uninformative Buy
58.29K
$2.48M
Elevation Oncology
―
―
―
―
OnKure Therapeutics
Oct 08, 2024
Director
Uninformative Buy
―
$14.57K
List of latest transactions for each holding click on a transaction to see R Michael Carruthers's performance on stock
You May Also Like
R Michael Carruthers insider profile FAQ
What is the percentage of profitable transactions made by R Michael Carruthers?
The percentage of profitable transactions made by R Michael Carruthers is 50%.
What is the average return per transaction made by R Michael Carruthers?
The average return per transaction made by R Michael Carruthers is -22.00%.
What stocks does R Michael Carruthers hold?
R Michael Carruthers holds: FRTX, EWTX, ELEV, OKUR stocks.
What was R Michael Carruthers’s latest transaction?
R Michael Carruthers latest transaction was an Uninformative Buy of ―.
What was R Michael Carruthers's most profitable transaction?
R Michael Carruthers’s most profitable transaction was an Informative Sell of EWTX stock on September 24, 2024. The return on the trade was 35.90%.
What is R Michael Carruthers's role in Fresh Tracks Therapeutics?
R Michael Carruthers's role in Fresh Tracks Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.